Catalyst Investors Ask Chancery To Pause Asia Purchase Vote
Stockholders of biopharmaceutical company Catalyst Biosciences Inc. have asked the Delaware Chancery Court to halt a scheduled stockholder vote until the company releases more information about its planned acquisition of a...To view the full article, register now.
Already a subscriber? Click here to view full article